Dongsung Pharm (002210) — Cash Flow-to-Debt Ratio
Dongsung Pharm (002210) has a Cash Flow-to-Debt Ratio of 0.04x as of June 2025, meaning its operating cash flow of ₩4.20 Billion could theoretically repay 0% of its total liabilities (₩107.40 Billion) in one year. Explore investment intensity of Dongsung Pharm to see how much of total assets are deployed in long-term investments.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Dongsung Pharm Cash Flow-to-Debt Ratio (2008–2024)
Historical debt coverage capacity for Dongsung Pharm across 13 annual periods. Also explore Dongsung Pharm (002210) total assets for the complete picture of this company's asset base.
Annual Cash Flow-to-Debt Ratio for Dongsung Pharm (2008–2024)
Year-by-year debt coverage analysis for Dongsung Pharm. For market capitalisation and broader financial context, see how much is Dongsung Pharm worth.
| Year | CF-to-Debt Ratio | Operating CF (KRW) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | -0.10x | ₩-9.94 Billion | ₩96.73 Billion | ▼ -80.0% |
| 2023 | -0.06x | ₩-4.29 Billion | ₩75.17 Billion | ▲ +4.5% |
| 2022 | -0.06x | ₩-3.88 Billion | ₩64.89 Billion | ▼ -26.4% |
| 2021 | -0.05x | ₩-2.75 Billion | ₩58.14 Billion | ▼ -166.9% |
| 2020 | 0.07x | ₩5.01 Billion | ₩70.77 Billion | ▲ +152.5% |
| 2019 | -0.13x | ₩-8.31 Billion | ₩61.63 Billion | ▼ -900.0% |
| 2018 | 0.02x | ₩1.39 Billion | ₩82.71 Billion | ▼ -43.9% |
| 2017 | 0.03x | ₩1.80 Billion | ₩59.91 Billion | ▲ +162.6% |
| 2016 | -0.05x | ₩-3.34 Billion | ₩69.77 Billion | ▼ -16.7% |
| 2011 | -0.04x | ₩-2.64 Billion | ₩64.38 Billion | ▼ -176.6% |
| 2010 | 0.05x | ₩3.68 Billion | ₩68.71 Billion | ▲ +164.0% |
| 2009 | -0.08x | ₩-5.02 Billion | ₩59.94 Billion | ▼ -1201.5% |
| 2008 | -0.01x | ₩-365.26 Million | ₩56.75 Billion | — |